International Clinical Psychopharmacology

SJR Rank #7,154H-index: 102SJR: 0.781Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Lippincott Williams and Wilkins

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Pharmacology (medical)Q2
  • Psychiatry and Mental HealthQ2

Areas: Medicine

Most published research topics

Schizophrenia research and treatmentTreatment of Major DepressionBipolar Disorder and TreatmentElectroconvulsive Therapy StudiesAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesObsessive-Compulsive Spectrum DisordersTryptophan and brain disordersNeurotransmitter Receptor Influence on BehaviorMental Health Research TopicsEpilepsy research and treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04590135180

Documents per Year

20222025015304560

Detailed Information

ISSN

0268-1315, 1473-5857

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

2.23

References per Document

47.38

Coverage

1986-2026

Scope

International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes. A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.

Metrics from SCImago Journal Rank 2025. View on SCImago